Midi Health vs Health Source Online
Compare pricing, features, and medications to find the best GLP-1 provider for your weight loss journey
Midi Health vs Health Source Online: Overview
Choosing between Midi Health and Health Source Online for GLP-1 weight loss medication? Both are popular providers, but they differ in pricing, medication options, and service features.
Midi Health offers both semaglutide and tirzepatide at $164/month with a rating of 8.6/10. Health Source Online also provides both semaglutide and tirzepatide at $299/month with a 7.4/10 rating.
The price difference of $135/month is significant - Midi Health is the more budget-friendly option, while Health Source Online positions itself as a premium service.
Our recommended brand
After reviewing all 148 providers on this platform, we've identified CoreAge Rx as offering the most transparent pricing model. At just $99/month — the same price every month, every dose — there are no surprise charges or hidden fees. Combined with exceptional service quality, personalized support, and access to both semaglutide and tirzepatide, it represents the best value without compromising on care.
At a glance
Price Difference
$135/mo
Rating Difference
1.2
Winner
Midi Health
Best For
Budget
Midi Health
View full Midi Health review →Rating
8.6/10Better
Monthly Price
$164Cheaper
Medications
compounded GLP-1compounded GLP-1/GIPbrand-name GLP-1s
Pros
- ✓The GLP-1 pricing page is the most transparent we have seen anywhere in this category: a dose-by-dose table for four different products, with shipping and supplies included in every figure (checked July 28, 2026)
- ✓Compounded GLP-1 injectable runs $165.90 for the lowest doses, $270.90 in the mid range and $355.00 at the top; the dual-action GLP-1/GIP injectable runs $210.00 to $434.00, all for a 4-week supply
- ✓Sublingual options are offered as well, from $164.00 for GLP-1 and $209.00 for dual-action GLP-1/GIP, for people who will not inject
- ✓Its partner compounding pharmacies are 503B-accredited. 503B outsourcing facilities register with the FDA, are subject to current good manufacturing practice requirements and are FDA-inspected - a materially higher standard than the 503A pharmacies most competitors use
- ✓There is no membership fee. You pay for care and medication only
- ✓Visits are insurance-covered for qualifying patients, and HSA/FSA funds can be used for copays and services
- ✓Midi will also prescribe brand-name GLP-1s sent to a pharmacy of your choice, so you are not locked into compounded product if you would rather have the approved drug
- ✓The efficacy claim is the best-sourced in this category. Midi reports patients lost an average of 16 lbs after six or more months, and footnotes it to a retrospective analysis of 6,958 patients who completed two or more weight management visits between 1 May 2025 and 30 April 2026, while stating plainly that weight data were self-reported and results are not guaranteed
- ✓Care is genuinely whole-person for midlife women - perimenopause, menopause, weight, mood and memory, sexual wellness, hair and skin, sleep, and cancer survivorship - with lab orders and lifestyle support included where appropriate
- ✓Available in all 50 states
Cons
- ✗The compounded products are still not FDA-approved. 503B accreditation raises the manufacturing standard considerably but does not mean the FDA has reviewed these preparations for safety or efficacy
- ✗Midi never names the active drug anywhere in its pricing. Everything is labelled 'GLP-1' or 'GLP-1/GIP'. The dose ladders shown - 0.25 through 2.5 mg, and 2.5 through 15 mg - match the standard semaglutide and tirzepatide titrations exactly, but you should confirm with the clinician what you are actually being prescribed
- ✗Microdosing is offered from $34 a week for eligible patients. Microdosing is not an evidence-based protocol - the trials behind these drugs used full therapeutic doses, and the 16 lb outcome figure covers patients on 'a range of treatments', not microdosing specifically
- ✗Medicaid and Medi-Cal patients cannot be treated at all, even if they offer to pay cash
- ✗Medicare does not cover Midi, and beneficiaries cannot submit claims for visits, medications or associated services
- ✗Prices rise steeply as you titrate up. Injectable GLP-1 more than doubles from $165.90 to $355.00, and the dual-action sublingual runs from $209.00 to $460.00, so the entry price is not what you will pay long term
- ✗The 16 lb average comes from self-reported weights in a retrospective chart review with no control group - well documented, but not a controlled trial
- ✗GLP-1 medications are not suitable for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, or during pregnancy. Pancreatitis and gallbladder disease are recognised risks
Health Source Online
View full Health Source Online review →Rating
7.4/10
Monthly Price
$299
Medications
semaglutidetirzepatideliraglutide
Pros
- ✓Programme prices are published per four-week cycle rather than hidden behind an intake: semaglutide from $299, and a range of other programmes from $179 to $600
- ✓Programmes cover medication, supplies and 24/7 access to your care team through a HIPAA-compliant platform
- ✓The partner pharmacy is described as a US-based, FDA 503A licensed facility
- ✓Same-day telehealth consultation with a board-certified physician after you complete the questionnaire
- ✓Delivery quoted at 3-5 business days with tracking supplied
- ✓An automatic refund mechanism that most competitors do not offer: "Subscription recurring payment auto-refund if monthly reassessment is not filled" - if you do not complete the monthly review, you are not charged for medication you were never reassessed for
- ✓BMI and progress tracking are built into the programme
- ✓A broad catalogue including liraglutide, which relatively few telehealth providers offer
Cons
- ✗The liraglutide programme does not include the medication. The page states outright: "The cost of Liraglutide medication is not included in this program" - the price buys the telehealth wrapper only, and the pharmacy negotiates the drug cost with your insurer separately
- ✗The same liraglutide page calls liraglutide "FDA-approved" while the pharmacy fulfilling it is described as a compounding pharmacy, which muddles what you are actually buying
- ✗Prices are quoted "from" a figure every four weeks, and four-weekly billing means 13 payments a year rather than 12
- ✗The dispensing pharmacy is not named
- ✗No phone number is published
- ✗No insurance billing, and HSA/FSA acceptance is not stated
- ✗The site markets a very wide catalogue of programmes, which makes it hard to tell how much clinical attention each one gets
Feature-by-feature comparison
| Feature | Midi Health | Health Source Online |
|---|---|---|
| Monthly Price | $164 | $299 |
| Rating | 8.6/10 | 7.4/10 |
| Medications | compounded GLP-1, compounded GLP-1/GIP, brand-name GLP-1s | semaglutide, tirzepatide, liraglutide |
| Insurance Accepted | Yes | No |
| Support Hours | Not published | Company advertises 24/7 chat with a board-certified physician or customer service |
| Live Chat | No | Available |
| Free Shipping | Yes | Yes |
| Shipping Speed | Discreet shipping included in every quoted medication price | 3-5 business days with tracking; next-day delivery cited on the semaglutide programme |
| Mobile App | No | No |
| Dedicated Coach | Not included | Not included |
| Follow-up Frequency | Continued care visits with the same clinician, covered by insurance for qualifying patients | Monthly reassessment required to keep the subscription running |
| Money-back Guarantee | None published | Recurring payment is auto-refunded if the monthly reassessment is not completed |
| Cancellation Policy | No membership fee and no subscription lock-in; you pay for care and medication only | Subscription programmes billed every 4 weeks; refund and returns policy published separately |
Which should you choose?
Choose Midi Health if you:
- →Want to save $135/month with a more affordable option
- →Prefer a higher-rated service (8.6/10 vs 7.4/10)
- →Need insurance coverage for your treatment
- →Value: the glp-1 pricing page is the most transparent we have seen anywhere in this category: a dose-by-dose table for four different products, with shipping and supplies included in every figure (checked july 28, 2026)
Choose Health Source Online if you:
- →Value: programme prices are published per four-week cycle rather than hidden behind an intake: semaglutide from $299, and a range of other programmes from $179 to $600
Website previews
Midi Health
Health Source Online
Our recommendation
Midi Health comes out ahead with a higher rating of 8.6/10. It also provides multiple medication options including both semaglutide and tirzepatide.
Get started with Midi HealthRelated comparisons
Midi Health vs CoreAge Rx
$164
★ 8.6
vs
$99
★ 9.6
Midi Health vs Zepbound
$164
★ 8.6
vs
$450
★ 9.3
Midi Health vs Mounjaro
$164
★ 8.6
vs
$1080
★ 9.2
Midi Health vs Wegovy Pill
$164
★ 8.6
vs
$149
★ 9.2
Midi Health vs Foundayo
$164
★ 8.6
vs
$149
★ 9.2
Midi Health vs Wegovy
$164
★ 8.6
vs
$349
★ 9.1
Midi Health vs NovoCare Pharmacy
$164
★ 8.6
vs
$149
★ 9
Midi Health vs Ozempic
$164
★ 8.6
vs
$349
★ 8.9
Midi Health vs Form Health
$164
★ 8.6
vs
$299
★ 8.8
Midi Health vs Henry Meds
$164
★ 8.6
vs
$179
★ 8.7
Midi Health vs Sesame Care
$164
★ 8.6
vs
$59
★ 8.7
Midi Health vs FuturHealth
$164
★ 8.6
vs
$225
★ 8.7
Midi Health vs Circle Medical
$164
★ 8.6
vs
$35
★ 8.7
Midi Health vs Ro
$164
★ 8.6
vs
$149
★ 8.6
Midi Health vs Noom Med
$164
★ 8.6
vs
$149
★ 8.6
Midi Health vs Precision Telemed
$164
★ 8.6
vs
$150
★ 8.6
Midi Health vs Hims
$164
★ 8.6
vs
$298
★ 8.5
Midi Health vs Calibrate
$164
★ 8.6
vs
$199
★ 8.5
Midi Health vs PlushCare
$164
★ 8.6
vs
$20
★ 8.5
Midi Health vs LifeMD
$164
★ 8.6
vs
$199
★ 8.5
Compare other providers
Compare GLP-1 Brands
vs